Arrowstreet Capital, Limited Partnership2026-Q1
This is ARROWSTREET CAPITAL, LIMITED PARTNERSHIP's 13F filing for 2026-Q1, covering the period ended March 31, 2026.
Quick Reference
| Ticker | Action | Value Change |
|---|---|---|
| AVGO | Add | +$2.83B |
| MSFT | Add | +$1.84B |
| SNDK | Trim | +$968.6M (trimmed, but value rose because price gain outweighed trimmed shares — not a buy) |
| SE | Sold out | a notable change |
| ADBE | Add | -$528.8M (added, but value fell because price drop outweighed added shares — not a sell) |
Q: Did Arrowstreet Capital buy or sell AVGO in Q1 2026? Arrowstreet Capital added to AVGO in Q1 2026. The position grew by +$2.83B, with portfolio weight rising from 1.74% to 3.14%.
Q: What was Arrowstreet Capital's biggest position increase in Q1 2026? AVGO was Arrowstreet's biggest position increase in Q1 2026, growing by +$2.83B. The stake went from $2.97B to $5.80B, lifting its portfolio weight from 1.74% to 3.14%.
Q: Did Arrowstreet Capital trim SNDK in Q1 2026? Arrowstreet trimmed SNDK in Q1 2026, but the position value still rose because the stock price gained more than the trimmed shares were worth — not a buy. The value moved by +$968.6M, and SNDK's portfolio weight went from 0.48% to 0.97%.
Q: Why did Arrowstreet Capital exit SE completely in Q1 2026? Arrowstreet sold out of SE entirely in Q1 2026; the 13F filing does not state a reason for the exit. The position had been worth $573.2M, equal to 0.34% of the portfolio, and now carries zero value.
Q: What new stocks did Arrowstreet Capital buy in Q1 2026? Arrowstreet opened new positions in CNQ, AZN, XOM, SHEL, PBR, PBR-A, CVX, TTE, and NVO. The largest new buy was CNQ at $1.41B, a 0.76% portfolio weight.
Q: What did Arrowstreet Capital do with ADBE in Q1 2026? Arrowstreet added to ADBE in Q1 2026, but the position's dollar value fell because the stock price dropped more than the added shares were worth — not a sell. The value moved by -$528.8M, and the portfolio weight shifted from 1.28% to 0.89%.
Q: Did Arrowstreet Capital trim Lam Research (LRCX) in Q1 2026? Arrowstreet trimmed LRCX in Q1 2026, but the value rose because the stock price gained more than the trimmed shares were worth — not a buy. The position moved by +$530.8M and its weight rose from 1.34% to 1.52%.
Q: What sector does Arrowstreet Capital have the most money in? Information Technology is Arrowstreet's largest sector weighting at 35.69% of the portfolio. Health Care follows at 11.06% and Consumer Discretionary at 10.77%.
Q: What was Arrowstreet Capital's portfolio turnover in Q1 2026? Arrowstreet's turnover ratio for Q1 2026 was 0.435153. That is up from 0.42373 in the prior quarter, and the fund held 1,810 positions at quarter-end versus 1,808 in the prior quarter.
Q: What's the easiest way to track Arrowstreet Capital's future filings? Check Arrowstreet Capital's next quarterly 13F filing when it is released for the following quarter. Each new filing will update the same position-level buy, sell, and weight data shown here.